Literature DB >> 18245089

Mitogen-activated protein kinase ERK1/2 regulates the class II transactivator.

Lilien N Voong1, Allison R Slater, Sebila Kratovac, Drew E Cressman.   

Abstract

The expression of major histocompatibility class II genes is necessary for proper antigen presentation and induction of an immune response. This expression is initiated by the class II transactivator, CIITA. The establishment of the active form of CIITA is controlled by a series of post-translational events, including GTP binding, ubiquitination, and dimerization. However, the role of phosphorylation is less clearly defined as are the consequences of phosphorylation on CIITA activity and the identity of the kinases involved. In this study we show that the extracellular signal-regulated kinases 1 and 2 (ERK1/2) interact directly with CIITA, targeting serine residues in the amino terminus of the protein, including serine 288. Inhibition of this phosphorylation by dominant-negative forms of ERK or by treatment of cells with the ERK inhibitor PD98059 resulted in the increase in CIITA-mediated gene expression from a class II promoter, enhanced the nuclear concentration of CIITA, and impaired its ability to bind to the nuclear export factor, CRM1. In contrast, inhibition of ERK1/2 activity had little effect on serine-to-alanine mutant forms of CIITA. These data suggest a model whereby ERK1/2-mediated phosphorylation of CIITA down-regulates CIITA activity by priming it for nuclear export, thus providing a means for cells to tightly regulate the extent of antigen presentation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18245089      PMCID: PMC2431044          DOI: 10.1074/jbc.M706487200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

Review 1.  A common set of factors control the expression of the MHC class II, invariant chain, and HLA-DM genes.

Authors:  J M Boss
Journal:  Microbes Infect       Date:  1999-09       Impact factor: 2.700

Review 2.  Regulating access to the genome: nucleocytoplasmic transport throughout the cell cycle.

Authors:  Karsten Weis
Journal:  Cell       Date:  2003-02-21       Impact factor: 41.582

3.  Sequential modifications in class II transactivator isoform 1 induced by lipopolysaccharide stimulate major histocompatibility complex class II transcription in macrophages.

Authors:  Gorazd Drozina; Jiri Kohoutek; Tadashi Nishiya; B Matija Peterlin
Journal:  J Biol Chem       Date:  2006-11-09       Impact factor: 5.157

4.  CREB and phospho-CREB interact with RFX5 and CIITA to regulate MHC class II genes.

Authors:  Jonathan Lochamy; Edward M Rogers; Jeremy M Boss
Journal:  Mol Immunol       Date:  2006-05-24       Impact factor: 4.407

5.  Identification of class II transcriptional activator-induced genes by representational difference analysis: discoordinate regulation of the DN alpha/DO beta heterodimer.

Authors:  D J Taxman; D E Cressman; J P Ting
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

6.  Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter.

Authors:  X S Zhu; M W Linhoff; G Li; K C Chin; S N Maity; J P Ting
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

7.  MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-gamma.

Authors:  Mojun Zhao; Frederick L Flynt; Mei Hong; Han Chen; Carolyn A Gilbert; Nicole T Briley; Sophia C Bolick; Kenneth L Wright; Janet F Piskurich
Journal:  Mol Immunol       Date:  2007-02-14       Impact factor: 4.407

8.  Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII.

Authors:  Maria Nikodemova; Jyoti J Watters; Samuel J Jackson; Shaun K Yang; Ian D Duncan
Journal:  J Biol Chem       Date:  2007-03-29       Impact factor: 5.157

9.  The GTP-binding domain of class II transactivator regulates its nuclear export.

Authors:  Aparna Raval; Jocelyn D Weissman; T Kevin Howcroft; Dinah S Singer
Journal:  J Immunol       Date:  2003-01-15       Impact factor: 5.422

10.  Role of PKCdelta in IFN-gamma-inducible CIITA gene expression.

Authors:  Myung-Ja Kwon; Yongxue Yao; Michael J Walter; Michael J Holtzman; Cheong-Hee Chang
Journal:  Mol Immunol       Date:  2007-03-07       Impact factor: 4.407

View more
  11 in total

1.  Phosphorylation and ubiquitination of degron proximal residues are essential for class II transactivator (CIITA) transactivation and major histocompatibility class II expression.

Authors:  Kavita Purnanda Bhat; Agnieszka Dorota Truax; Susanna Fletcher Greer
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

2.  PCB exposure and potential future cancer incidence in Slovak children: an assessment from molecular finger printing by Ingenuity Pathway Analysis (IPA®) derived from experimental and epidemiological investigations.

Authors:  Somiranjan Ghosh; Christopher A Loffredo; Partha S Mitra; Tomas Trnovec; Lubica Palkovicova Murinova; Eva Sovcikova; Eric P Hoffman; Kepher H Makambi; Sisir K Dutta
Journal:  Environ Sci Pollut Res Int       Date:  2017-11-15       Impact factor: 4.223

3.  Anthrax lethal toxin impairs CD1d-mediated antigen presentation by targeting the extracellular signal-related kinase 1/2 mitogen-activated protein kinase pathway.

Authors:  Masood A Khan; Richard M Gallo; Randy R Brutkiewicz
Journal:  Infect Immun       Date:  2010-03-01       Impact factor: 3.441

4.  Global gene expression and Ingenuity biological functions analysis on PCBs 153 and 138 induced human PBMC in vitro reveals differential mode(s) of action in developing toxicities.

Authors:  Somiranjan Ghosh; Shizhu Zang; Partha S Mitra; Svetlana Ghimbovschi; Eric P Hoffman; Sisir K Dutta
Journal:  Environ Int       Date:  2011-04-05       Impact factor: 9.621

5.  Stable protein, unstable plaque?

Authors:  Nicholas E S Sibinga
Journal:  J Mol Cell Cardiol       Date:  2008-12-03       Impact factor: 5.000

Review 6.  Regulating the activity of class II transactivator by posttranslational modifications: exploring the possibilities.

Authors:  Xiaoyan Wu; Xiaocen Kong; Larry Luchsinger; Barbara D Smith; Yong Xu
Journal:  Mol Cell Biol       Date:  2009-08-31       Impact factor: 4.272

7.  Development of potent class II transactivator gene delivery systems capable of inducing de novo MHC II expression in human cells, in vitro and ex vivo.

Authors:  M L Palma; P Duangkhae; B Douradinha; I F T Viana; P O Rigato; R Dhalia; R B Mailliard; S M Barratt-Boyes; E J M Nascimento; T M Oshiro; A J da Silva Duarte; E T A Marques
Journal:  Gene Ther       Date:  2017-04-17       Impact factor: 4.184

8.  The class II transactivator (CIITA) is regulated by post-translational modification cross-talk between ERK1/2 phosphorylation, mono-ubiquitination and Lys63 ubiquitination.

Authors:  Julie E Morgan; Ronald L Shanderson; Nathaniel H Boyd; Ercan Cacan; Susanna F Greer
Journal:  Biosci Rep       Date:  2015-06-19       Impact factor: 3.840

Review 9.  Understanding the Impact of ErbB Activating Events and Signal Transduction on Antigen Processing and Presentation: MHC Expression as a Model.

Authors:  Anna E Kersh; Maiko Sasaki; Lee A Cooper; Haydn T Kissick; Brian P Pollack
Journal:  Front Pharmacol       Date:  2016-09-26       Impact factor: 5.810

10.  miR-217 regulates tumor growth and apoptosis by targeting the MAPK signaling pathway in colorectal cancer.

Authors:  Nan Zhang; Canrong Lu; Lin Chen
Journal:  Oncol Lett       Date:  2016-10-13       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.